Xiaoying Chen

Australia

Global Project Manager

BSci

Xiaoying Chen is the global project manager working in the ENCHANTED study since she relocated to Australia in 2012. Before that she was working in the George Clinical China as a project manager across several large international clinical trials since 2008. She has more than 10-years’ experience in clinical research, project management and quality assurance both in Australia and China.

Xiaoying Chen

Characteristics, management and response to alteplase in China versus non-China participants of the ENCHANTED trial

Intracerebral hemorrhage location and outcome among INTERACT2 participants

White blood cell count and clinical outcomes after intracerebral hemorrhage: The INTERACT2 trial

Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke

Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 x 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs.

The George Institute for Global Health

The George Institute country sites:

Affiliation/s